Key facts
- It has raised $4.5M; the latest was Seed Round ($4.5M) in Nov 2025.
- Notable investors include National Institutes of Health, Mayo Clinic, First Spark Ventures, Angel Physicians Fund, C3 Ventures (VC).
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for FemtoVox
- ·The full record, as it builds
Funding rounds
No funding rounds for FemtoVox are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About FemtoVox
Developer of a laser technology designed for ear, nose, and throat surgery. The company's technology features the ability to cut tissue with less damage and remove tissue below the surface without cutting the epithelium, enabling surgeons to improve surgical workflow and clinical outcomes.
- Sector
- Healthcare
- HQ
- Ladera Ranch, CA, United States
- Founded
- 2022
- Employees
- 8
- Website
- femtovox.com/
- Ownership
- Privately Held (backing)
FemtoVox doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in FemtoVox shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on FemtoVox in its N-PORT filings yet. We sweep new filings monthly.